Literature DB >> 19924258

Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Gene L Bowman1, Joseph F Quinn.   

Abstract

Entities:  

Year:  2008        PMID： 19924258      PMCID： PMC2778025          DOI： 10.2217/1745509X.4.1.47

Source DB:  PubMed          Journal:  Aging health        ISSN： 1745-509X


× No keyword cloud information.
  70 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease.

Authors:  P Eikelenboom; C E Hack; W Kamphorst; J M Rozemuller
Journal:  Res Immunol       Date:  1992 Jul-Aug

3.  Amyloid angiopathy and blood-brain barrier changes in Alzheimer's disease.

Authors:  H M Wisniewski; A W Vorbrodt; J Wegiel
Journal:  Ann N Y Acad Sci       Date:  1997-09-26       Impact factor: 5.691

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  Rapid dynamic CT scanning in primary degenerative dementia and age-matched controls.

Authors:  M W Dysken; M J Nelson; K M Hoover; M Kuskowski; R McGeachie
Journal:  Biol Psychiatry       Date:  1990-09-01       Impact factor: 13.382

6.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

7.  Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

Authors:  K Blennow; A Wallin; P Fredman; C G Gottfries; I Karlsson; L Svennerholm
Journal:  Eur Neuropsychopharmacol       Date:  1990-11       Impact factor: 4.600

8.  Quantitative measurements of capillary transport in human brain tumors by computed tomography.

Authors:  D R Groothuis; F J Vriesendorp; B Kupfer; P C Warnke; G D Lapin; A Kuruvilla; N A Vick; M A Mikhael; C S Patlak
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

9.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.

Authors:  M R Malinow; F J Nieto; M Szklo; L E Chambless; G Bond
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

10.  Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Authors:  G L Bowman; J A Kaye; M Moore; D Waichunas; N E Carlson; J F Quinn
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910
View more
  15 in total

1.  Ascorbic acid and rates of cognitive decline in Alzheimer's disease.

Authors:  Gene L Bowman; Hiroko Dodge; Balz Frei; Carlo Calabrese; Barry S Oken; Jeffrey A Kaye; Joseph F Quinn
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 2.  Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.

Authors:  Helga E de Vries; Gijs Kooij; Dan Frenkel; Spiros Georgopoulos; Alon Monsonego; Damir Janigro
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

3.  Neurobiology of vascular dementia.

Authors:  Ana-Maria Enciu; Stefan N Constantinescu; Laurenţiu M Popescu; Dafin F Mureşanu; Bogdan O Popescu
Journal:  J Aging Res       Date:  2011-08-17

4.  A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.

Authors:  Jonathan D'Arcy Rudge
Journal:  J Alzheimers Dis Rep       Date:  2022-03-25

5.  Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.

Authors:  Ying Wang; Mingfei Li; Lewis E Kazis; Weiming Xia
Journal:  Alzheimers Dement       Date:  2022-04-04       Impact factor: 16.655

6.  A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.

Authors:  Christian Freese; Sven Reinhardt; Gudrun Hefner; Ronald E Unger; C James Kirkpatrick; Kristina Endres
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

7.  Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.

Authors:  Zohara Sternberg; Zihua Hu; Daniel Sternberg; Shayan Waseh; Joseph F Quinn; Katharine Wild; Kaye Jeffrey; Lin Zhao; Michael Garrick
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

8.  A quantitative brain map of experimental cerebral malaria pathology.

Authors:  Patrick Strangward; Michael J Haley; Tovah N Shaw; Jean-Marc Schwartz; Rachel Greig; Aleksandr Mironov; J Brian de Souza; Sheena M Cruickshank; Alister G Craig; Danny A Milner; Stuart M Allan; Kevin N Couper
Journal:  PLoS Pathog       Date:  2017-03-08       Impact factor: 6.823

Review 9.  Blood Brain Barrier and Alzheimer's Disease: Similarity and Dissimilarity of Molecular Alerts.

Authors:  Alla P Toropova; Andrey A Toropov; Sanija Begum; Patnala G R Achary
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 10.  In Vivo Imaging of Human Neuroinflammation.

Authors:  Daniel S Albrecht; Cristina Granziera; Jacob M Hooker; Marco L Loggia
Journal:  ACS Chem Neurosci       Date:  2016-03-25       Impact factor: 4.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.